Literature DB >> 2864069

A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.

K Stumpe, R Kolloch, M Mathieu, P Capone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864069

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN: 0262-8767


× No keyword cloud information.
  10 in total

Review 1.  Exercise metabolism and beta-blocker therapy. An update.

Authors:  A Head
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

Review 2.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 3.  Efficacy of celiprolol in hypertension and angina pectoris. Introduction.

Authors:  R J Norris
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

Review 4.  Progress in antihypertensive therapy with a multiple-action drug.

Authors:  B N Prichard; B Tomlinson
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 5.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

6.  Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.

Authors:  A Head; S Maxwell; M J Kendall
Journal:  Br J Sports Med       Date:  1997-06       Impact factor: 13.800

Review 7.  Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.

Authors:  C J Dunn; C M Spencer
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

Review 8.  A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.

Authors:  M J Kendall; I Rajman
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 9.  Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.

Authors:  J G Riddell; R G Shanks; R N Brogden
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

Review 10.  Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.

Authors:  Gavin W K Wong; Heidi N Boyda; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2016-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.